ATE428403T1
Stabilized azithromycin compositions
Abstract
Compositions and methods of stabilizing azithromycin compositions are described. Stabilized azithromycin compositions comprise an intimate admixture of azithromycin and a stabilizing-effective amount of an antioxidant to improve the resistance of the azithromycin to degradation. Coprecipitation or co-milling of azithromycin and an antioxidant are particularly preferred means of achieving an intimate admixture. Pharmaceutical formulations comprising a stabilized azithromycin composition and methods of making such formulations are also described.
Term
Term ended
Projected expiry passed 18 October 2022, 3.9 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
40 members in 14 offices
Priority claims4
| Document | Office | Kind | Date |
|---|---|---|---|
| 33634601 | United States of America | P | |
| 33193101 | United States of America | P | |
| 34129501 | United States of America | P | |
| 0233339 | United States of America | W |
Members40
| Document | Office | Kind | |
|---|---|---|---|
| CA2463619A1 | Canada | A1 | |
| WO03032922A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2002335087A1 | Australia | A1 | |
| US2003176369A1 | United States of America | A1 | |
| WO03032922A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US6669502B1 | United States of America | B1 | |
| WO2004027934A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2003272544A1 | Australia | A1 | |
| US6764997B2 | United States of America | B2 | |
| EP1446010A2 | European Patent Office (EPO) | A2 | |
| CA2517004A1 | Canada | A1 | |
| WO2004074132A1 | World Intellectual Property Organization (WIPO) | A1 | |
| IL161398A0 | Israel | A0 | |
| US2004192622A1 | United States of America | A1 | |
| US2004226852A1 | United States of America | A1 | |
| HU0402291A2 | Hungary | A2 | |
| HUP0402291A2 | Hungary | A2 | |
| HK1067278A | Hong Kong, China | A | |
| HK1067278A1 | Hong Kong, China | A1 | |
| US2005106239A1 | United States of America | A1 | |
| EP1540771A1 | European Patent Office (EPO) | A1 | |
| EP1541134A2 | European Patent Office (EPO) | A2 | |
| CN1689195A | China | A | |
| EP1594762A1 | European Patent Office (EPO) | A1 | |
| HK1081728A1 | Hong Kong, China | A1 | |
| EP1541134A3 | European Patent Office (EPO) | A3 | |
| EP1446010A4 | European Patent Office (EPO) | A4 | |
| US2007199856A1 | United States of America | A1 | |
| CA2463619C | Canada | C | |
| US2008149521A9 | United States of America | A9 | |
| CN100403599C | China | C | |
| EP1540771B1 | European Patent Office (EPO) | B1 | |
| DE60325386D1 | Germany | D1 | |
| EP1446010B1 | European Patent Office (EPO) | B1 | |
| AT428403T | Austria | T | |
| ATE428403T1This record | Austria | T1 | |
| DE60232005D1 | Germany | D1 | |
| PT1446010E | Portugal | E | |
| DK1446010T3 | Denmark | T3 | |
| ES2324527T3 | Spain | T3 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER | RER |
Numbers
- Application
- 2801784
Titles2
- German
- STABILISIERTE AZITHROMYCIN-ZUSAMMENSETZUNGEN
- English
- STABILIZED AZITHROMYCIN COMPOSITIONS
Classification
- CPC, 6
- A61K9/1617
- A61K9/0095
- A61K9/145
- A61K9/2077
- A61K31/7052
- A61P31/04
- IPC, 10
- A61K9 00
- A61K9 14
- A61K9 16
- A61K9 20
- A61K31 353
- A61K31 375
- A61K31 70
- A61K31 7048
- A61K31 7052
- A61K47 10